Non-toxic derivatives of LT as potent adjuvants.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Vaccine

• Publication date

  2011-02-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.vaccine.2010.11.091PMID 21163247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative study on characterization of recombinant B subunit of E. coli heat-labile enterotoxin (rLTB) prepared from E. coli and P. patoris.

  2010cited by this paper
• Tissue culture and expression of Escherichia coli heat-labile enterotoxin B subunit in transgenic Peperomia pellucida.

  2010cited by this paper
• New adjuvants for human vaccines.

  2010cited by this paper
• Recombinant Escherichia coli heat-labile enterotoxin B subunit humoral adjuvant effect depends on dose and administration route

  2010cited by this paper
• Expression and Immunogenicity of Enterotoxigenic Escherichia coli Heat-Labile Toxin B Subunit in Transgenic Rice Callus

  2010cited by this paper
• Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.

  2009cited by this paper
• Effective CD8(+) T cell priming and tumor protection by enterotoxin B subunit-conjugated peptides targeted to dendritic cells.

  2009cited by this paper
• Prolonged Protection against Intranasal Challenge with Influenza Virus following Systemic Immunization or Combinations of Mucosal and Systemic Immunizations with a Heat-Labile Toxin Mutant

  2009cited by this paper
• New horizons in adjuvants for vaccine development.

  2009cited by this paper
• Enhancement of mucosal immune response against the M2eHBc+ antigen in mice with the fusion expression products of LTB and M2eHBc+ through mucosal immunization route

  2009cited by this paper
• Influence of the A and B subunits of cholera toxin (CT) and Escherichia coli toxin (LT) on TNF-alpha release from macrophages.

  2009cited by this paper
• Mucosal immunity in mice induced by orally administered transgenic rice.

  2009cited by this paper
• Mechanism of action of licensed vaccine adjuvants.

  2009cited by this paper
• Expression of functional pentameric heat-labile enterotoxin B subunit of Escherichia coli in Saccharomyces cerevisiae.

  2009cited by this paper
• Secretory Expression and Purification of Recombinant Escherichia coli Heat-Labile Enterotoxin B Subunit and its Applications on Intranasal Vaccination of Hantavirus

  2009cited by this paper
• Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge.

  2009cited by this paper
• Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice

  2009cited by this paper
• The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response.

  2008cited by this paper
• Secretory and GM1 receptor binding role of N-terminal region of LTB in Vibrio cholerae.

  2008cited by this paper
• B subunit of Escherichia coli heat-labile enterotoxin as adjuvant of humoral immune response in recombinant BCG vaccination.

  2008cited by this paper
• Enhancement of vaccine potency by fusing modified LTK63 into human papillomavirus type 16 chimeric virus-like particles.

  2008cited by this paper
• Sublingual vaccination with influenza virus protects mice against lethal viral infection

  2008cited by this paper
• Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006.

  2008cited by this paper
• Synthesis and assembly of Escherichia coli heat-labile enterotoxin B subunit in transgenic lettuce (Lactuca sativa).

  2007cited by this paper
• Effects of LT‐K63 and CpG2006 on Phenotype and Function of Murine Neonatal Lymphoid Cells

  2007cited by this paper
• Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72.

  2007cited by this paper
• Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects.

  2007cited by this paper
• The Acquired Immune Response to the Mucosal Adjuvant LTK63 Imprints the Mouse Lung with a Protective Signature

  2007cited by this paper
• The perfect mix: recent progress in adjuvant research

  2007cited by this paper
• Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers

  2006cited by this paper
• B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination.

  2006cited by this paper
• Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin.

  2006cited by this paper
• A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice.

  2006cited by this paper
• Heat labile enterotoxin of E. coli: a potential adjuvant for transcutaneous cancer immunotherapy.

  2006cited by this paper
• "Immunopotentiators in Modern Vaccines" (IMV-II) held in Malaga, Spain, May 18-20, 2005.

  2006cited by this paper
• Targeting the innate immune response with improved vaccine adjuvants

  2005cited by this paper
• Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast.

  2005cited by this paper
• CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B® HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study

  2004cited by this paper
• Expression of non-toxic mutant of Escherichia coli heat-labile enterotoxin in tobacco chloroplasts.

  2004cited by this paper
• Innate Imprinting by the Modified Heat-Labile Toxin of Escherichia coli (LTK63) Provides Generic Protection against Lung Infectious Disease1

  2004cited by this paper
• Modulation of dendritic cell endocytosis and antigen processing pathways by Escherichia coli heat-labile enterotoxin and mutant derivatives.

  2003cited by this paper
• Recent advances in the discovery and delivery of vaccine adjuvants

  2003cited by this paper
• Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

  2002cited by this paper
• Enhanced Delivery of Exogenous Peptides into the Class I Antigen Processing and Presentation Pathway

  2002cited by this paper
• Toll-like receptors as adjuvant receptors.

  2002cited by this paper
• Medicine at the medical center then and now: one hundred years of progress.

  2002cited by this paper
• Modulation of B lymphocyte signalling by the B subunit of Escherichia coli heat-labile enterotoxin.

  2002cited by this paper
• Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli Vaccine Administered Transcutaneously

  2002cited by this paper
• Rotavirus 2/6 Virus-Like Particles Administered Intranasally in Mice, with or without the Mucosal Adjuvants Cholera Toxin and Escherichia coli Heat-Labile Toxin, Induce a Th1/Th2-Like Immune Response

  2001cited by this paper
• Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant.

  2001cited by this paper
• Immunomodulation Using Bacterial Enterotoxins

  2001cited by this paper
• Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

  2001cited by this paper
• Genetically Manipulated Bacterial Toxin as a New Generation Mucosal Adjuvant

  2001cited by this paper
• Protective Mucosal Immunity to Ocular Herpes Simplex Virus Type 1 Infection in Mice by Using Escherichia coli Heat-Labile Enterotoxin B Subunit as an Adjuvant

  2001cited by this paper
• Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity.

  2001cited by this paper
• Intranasal Immunization with SAG1 and Nontoxic Mutant Heat-Labile Enterotoxins Protects Mice againstToxoplasma gondii

  2001cited by this paper
• Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4(+) T cells.

  2001cited by this paper
• Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pyloriInfection

  2000cited by this paper
• Immune modulation by the cholera-like enterotoxin B-subunits: from adjuvant to immunotherapeutic.

  2000cited by this paper
• Modulation of Innate and Acquired Immune Responses by Escherichia coli Heat-Labile Toxin: Distinct Pro- and Anti-Inflammatory Effects of the Nontoxic AB Complex and the Enzyme Activity1

  2000cited by this paper
• Immunogenicity of the B Monomer ofEscherichia coli Heat-Labile Toxin Expressed on the Surface of Streptococcus gordonii

  2000cited by this paper
• Effects of Site-Directed Mutagenesis ofEscherichia coli Heat-Labile Enterotoxin on ADP-Ribosyltransferase Activity and Interaction with ADP-Ribosylation Factors

  1999cited by this paper
• Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat‐labile enterotoxin

  1999cited by this paper
• Mutants of Escherichia coli Heat-Labile Toxin Act as Effective Mucosal Adjuvants for Nasal Delivery of an Acellular Pertussis Vaccine: Differential Effects of the Nontoxic AB Complex and Enzyme Activity on Th1 and Th2 Cells

  1999cited by this paper
• MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants.

  1999cited by this paper
• Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity

  1998cited by this paper
• Levels of Expression and Immunogenicity of Attenuated Salmonella enterica Serovar Typhimurium Strains Expressing Escherichia coli Mutant Heat-Labile Enterotoxin

  1998cited by this paper
• Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat‐labile enterotoxin and its B subunit

  1998cited by this paper
• Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin

  1997cited by this paper
• Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loop

  1997cited by this paper
• Adjuvants--a classification and review of their modes of action.

  1997cited by this paper
• Modulation of B‐cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up‐regulates MHC class II, B7, CD40, CD25 and ICAM‐1

  1997cited by this paper
• Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

  1995cited by this paper
• A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit

  1994cited by this paper
• Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin.

  1993cited by this paper
• Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin.

  1992cited by this paper
• Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli

  1991cited by this paper
• Heat-labile enterotoxin in Escherichia coli. Kinetics of association of subunits into periplasmic holotoxin.

  1985cited by this paper
• Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans.

  1984cited by this paper
• Origin of the enzymatically active A1 fragment of cholera toxin.

  1979cited by this paper
• Origin of the Enzymatically Active AI Fragment of Cholera Toxin

  1979cited by this paper

• An In Silico-Designed Chimeric Antigen Confers Broad Protection Against Major Diarrheal Pathogens (Shigella, ETEC, and EHEC) in Preclinical Models.

  2026cites this paper
• Escherichia coli Heat-Labile Enterotoxin B Subunit as an Adjuvant of mucosal Immune Combined with GCRV-II VP6 Triggers Innate Immunity and Enhances Adaptive Immune Responses Following Oral Vaccination of Grass Carp (Ctenopharyngodon idella).

  2024cites this paper
• The heterologous expression of novel recombinant protein composed of HN and F moieties of Newcastle disease virus and immunogenicity evaluation in mouse model

  2024cites this paper
• Adjuvants for Helicobacter pylori vaccines: Outer membrane vesicles provide an alternative strategy

  2024cites this paper
• Escherichia coli LTB26 mutant enhances immune responses to rotavirus antigen VP8 in a mouse model.

  2024cites this paper
• Oral Live-Carrier Vaccine of Recombinant Lactococcus lactis Inducing Prophylactic Protective Immunity Against Helicobacter pylori Infection

  2024cites this paper
• Design, preparation and characterization of octopus-like self-releasing intracellular protein transporter LEB5 based on Escherichia coli heat-labile enterotoxin.

  2023cites this paper
• Challenges and Strategies for Developing Recombinant Vaccines against Leptospirosis: Role of Expression Platforms and Adjuvants in Achieving Protective Efficacy

  2023cites this paper
• Production and immunogenicity assessment of a ToxA-based multiepitope plant-made protein targeting enteric pathogens

  2023cites this paper
• Recent advances in respiratory immunization: A focus on COVID-19 vaccines

  2023cites this paper
• The role of diets in maternal vaccinations against typhoid toxin

  2022cites this paper
• Bacterial AB toxins and host-microbe interactions.

  2022cites this paper
• Malnutrition and maternal vaccination against typhoid toxin

  2022cites this paper
• THE B SUBUNIT OF Escherichia coli TOXIN LT FUSED WITH TRUNCATED rROP2 PROTEIN OF Neospora caninum INDUCES MIXED Th2/Th17 IMMUNE RESPONSE IN MICE

  2022cites this paper
• Adjuvants: friends in vaccine formulations against infectious diseases

  2021cites this paper
• Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity

  2021cites this paper
• Immunization with recombinant Erns-LTB fusion protein elicits protective immune responses against bovine viral diarrhea virus.

  2021cites this paper
• Current Status for Controlling the Overlooked Caprine Fasciolosis

  2021cites this paper
• Evaluation of Immunogenicity and Efficacy of Fasciola hepatica Tetraspanin 2 (TSP2) Fused to E. coli Heat-Labile Enterotoxin B Subunit LTB Adjuvant Following Intranasal Vaccination of Cattle

  2021cites this paper
• Tạo dòng và biểu hiện protein dung hợp LTB-STB của Enterotoxigenic Escherichia coli gây tiêu chảy trên heo con

  2020cites this paper
• SARS-COV-2 RBD Oral Vaccine Boosted by Mucosal Immune Adjuvant LTB26 via DCs and B Cells Activation in Mice

  2020cites this paper
• A Heat-labile Enterotoxin B Subunit Mutant (LTB26) of Escherichia coli Enhances Mucosal Immune adjuvanticity via Increased BCR Activity

  2020cites this paper
• Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization.

  2020cites this paper
• Inferring Toll-Like Receptor induced epitope subunit vaccine candidate against SARS-CoV-2: A Reverse Vaccinology approach

  2020cites this paper
• A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.

  2019cites this paper
• Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria

  2019cites this paper
• Application of built-in adjuvants for epitope-based vaccines

  2019cites this paper
• Different types of adjuvants in prophylactic and therapeutic human papillomavirus vaccines in laboratory animals: a systematic review

  2019cites this paper
• Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice

  2019cites this paper
• Chimera of Heat-labile Enterotoxin B chain conjugate with LipL32 and or LipL21 proteins induces strong reactive antibodies in experimental mice

  2018cites this paper
• Adjuvant and Antigen Systems for Malaria Transmission‐Blocking Vaccines

  2018cites this paper
• Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice.

  2018cites this paper
• How far are we from vaccination against Helicobacter pylori infection?

  2018cites this paper
• Adaptive immunity of airway inflammation in asthma

  2018cites this paper
• 6 – Evolution of Adjuvants Across the Centuries

  2018cites this paper
• Endogenous and Exogenous Natural Adjuvants for Vaccine Development.

  2017cites this paper
• Characterization of the A subunit epitopes in immunogenicity and enterotoxicity of enterotoxigenic Escherichia coli (ETEC) heat-labile toxin

  2017cites this paper
• Plant-based vaccines against respiratory diseases: current status and future prospects

  2017cites this paper
• Patching it together: epicutaneous vaccination with heat‐labile Escherichia coli toxin against birch pollen allergy

  2017cites this paper
• Immunogenicity of recombinant Lactobacillus casei‐expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat‐labile enterotoxin A (LTAK63) and heat‐labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice

  2017cites this paper
• Dendritic Cell-Mediated Mechanisms Triggered by LT-IIa-B5, a Mucosal Adjuvant Derived from a Type II Heat-Labile Enterotoxin of Escherichia coli.

  2017cites this paper
• Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice

  2017cites this paper
• Imunogenicidade da proteína M recombinante de Streptococcus equi subsp. equi coadministrada com um adjuvante molecular

  2017cites this paper
• Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein

  2017cites this paper
• Effects of microcystins toxins contaminated drinking water on hepatic problems in animals (cows and buffalos) and toxins removal chemical method

  2017cites this paper
• Elucidating Bottlenecks to the Efficient Preparation of AB5-Hexamer Mucosal Adjuvant Protein LTm by Genetic Engineering.

  2017cites this paper
• Current developments and prospects on human metapneumovirus vaccines

  2017cites this paper
• Microbiological Botulinum Toxins Removing From Drinking Water Sources by Treatment of Coagulation Process

  2016cites this paper
• Immunogenic properties of trivalent recombinant protein composed of B-subunits of LT, STX-2, and CT toxins.

  2016cites this paper
• Discovery of the cell-penetrating function of A2 domain derived from LTA subunit of Escherichia coli heat-labile enterotoxin

  2016cites this paper
• Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants

  2016cites this paper
• Effect of Boiling on Removing of Microcystins Toxins from Drinking Water Samples

  2016cites this paper
• Effect of Boiling on Removing of Botulinum Toxins from Drinking Water Samples

  2016cites this paper
• Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice.

  2016cites this paper
• Effect of Toxins (Microcystines, Shiga & Botulinum) on Liver Functions

  2016cites this paper
• Quantitative Proteomic Analysis of Escherichia coli Heat-Labile Toxin B Subunit (LTB) with Enterovirus 71 (EV71) Subunit VP1

  2016cites this paper
• A Novel Method for Efficient Preparation of Mucosal Adjuvant Escherichia coli Heat-Labile Enterotoxin Mutant (LTm) by Artificially Assisted Self-Assembly In Vitro

  2016cites this paper
• Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.

  2015cites this paper
• Current status of viral expression systems in plants and perspectives for oral vaccines development

  2015cites this paper
• The B subunit of Escherichia coli heat-labile toxin alters the development and antigen-presenting capacity of dendritic cells

  2015cites this paper
• Mucosal immunity induced by gliadin-presenting spores of Bacillus subtilis in HLA-DQ8-transgenic mice.

  2015cites this paper
• An overview of tuberculosis plant-derived vaccines

  2015cites this paper
• The Potential of Neospora caninum Immunogens against Neosporosis

  2015cites this paper
• Alzheimer's disease vaccine development: A new strategy focusing on immune modulation.

  2015cites this paper
• Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial.

  2015cites this paper
• Advances and challenges in mucosal adjuvant technology.

  2015cites this paper
• Local and systemic immune responses induced by a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens fused to the B subunit of Escherichia coli heat-labile enterotoxin LTB.

  2014cites this paper
• Immunogenicity and In Vitro and In Vivo Protective Effects of Antibodies Targeting a Recombinant Form of the Streptococcus mutans P1 Surface Protein

  2014cites this paper
• Construction and Characterization of Non-Toxic Bacterial Enterotoxins as Vaccine Adjuvants

  2014cites this paper
• Recombinant Neisseria surface protein A is a potential vaccine candidate against Neisseria meningitides serogroup B.

  2014cites this paper
• A CssA, CssB and LTB chimeric protein induces protection against Enterotoxigenic Escherichia coli

  2014cites this paper
• Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.

  2014cites this paper
• Mucosal vaccines

  2014cites this paper
• Alga-Produced Cholera Toxin-Pfs25 Fusion Proteins as Oral Vaccines

  2013cites this paper
• Mucosal and Systemic Immune Responses to Mycobacterium tuberculosis Antigen 85A following Its Co-Delivery with CpG, MPLA or LTB to the Lungs in Mice

  2013cites this paper
• Production and Evaluation of a Recombinant Chimeric Vaccine against Clostridium botulinum Neurotoxin Types C and D

  2013cites this paper
• Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice

  2013cites this paper
• Why does allergic contact dermatitis exist?

  2013cites this paper
• Safety and Immunogenicity of a Single Oral Dose of Recombinant Double Mutant Heat-Labile Toxin Derived from Enterotoxigenic Escherichia coli

  2013cites this paper
• Pediatric Immunology and Vaccinology

  2013cites this paper
• Immune responses following vaccination of pigs and mice against Mycoplasma hyopneumoniae

  2013cites this paper
• 5 – Evolution of adjuvants across the centuries

  2013cites this paper
• Can mucosal adjuvants contribute to the induction of immunological memory induced via unconjugated T-cell-independent antigens?

  2012cites this paper
• UNIVERSIDADE FEDERAL DE PELOTAS Programa de Pós-Graduação em Veterinária

  2012cites this paper
• Structure and activity of Clostridium botulinum neurotoxin functional fragments

  2012cites this paper
• Oral Administration Recombinant Bifidobacterium-LTB (B Subunit of Heat-Labile Enterotoxin) Enhances the OVA (Ovalbumin)-Specific sIgA in Jejunal Mucosa of Sprague-Dawley (SD) Rat

  2012cites this paper
• Safety and immunogenicity of bacterial and tobacco plant cell line derived recombinant native and mutant Escherichia coli heat-labile toxin in chickens

  2012cites this paper
• Protection against Lethal Leptospirosis after Vaccination with LipL32 Coupled or Coadministered with the B Subunit of Escherichia coli Heat-Labile Enterotoxin

  2012cites this paper
• The B Subunit of an AB5 Toxin Produced by Salmonella enterica Serovar Typhi Up-Regulates Chemokines, Cytokines, and Adhesion Molecules in Human Macrophage, Colonic Epithelial, and Brain Microvascular Endothelial Cell Lines

  2012cites this paper
• Oral immunisation of mice with a recombinant rabies virus vaccine incorporating the heat-labile enterotoxin B subunit of Escherichia coli in an attenuated Salmonella strain.

  2012cites this paper
• A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coli.

  2012cites this paper
• Structure-activity correlations of variant forms of the B pentamer of Escherichia coli type II heat-labile enterotoxin LT-IIb with Toll-like receptor 2 binding.

  2012cites this paper
• Effets de différents adjuvants de la famille de la toxine du choléra sur les lymphocytes T CD4 dans un modèle murin d'immunisation intrarectale avec des pseudoparticules virales de rotavirus

  2011cites this paper
• Selection of Adjuvants for Enhanced Vaccine Potency

  2011cites this paper
• The Thai Journal of Veterinary Medicine The Thai

  year unknowncites this paper